NON-APOPTOTIC ACTION OF CASPASES IN PLURIPOTENT EMBRYONIC STEM CELLS
NON-APOPTOTIC ACTION OF CASPASES IN PLURIPOTENT EMBRYONIC STEM CELLS
批准号:
8269736
负责人:
Thomas P. Zwaka
金额:
$30.09万
依托单位国家:
美国
项目类别:
财政年份:
2008
资助国家:
美国
项目状态:
已结题
起止时间:
2008-08-01 至 2014-05-31
关键词:
AddressAffectApoptosisApoptoticCaspaseCell DeathCellsCleaved cellClinicalDevelopmentDevelopmental BiologyDiseaseEnzymesGoalsHuman bodyIn VitroKnock-outLinkMeasuresMediatingMediator of activation proteinMolecularPathway interactionsPhenotypePluripotent Stem CellsProcessProteinsRegenerative MedicineRegulationResistanceRoleSignal TransductionSmall Interfering RNASystemTestingUndifferentiatedWorkcaspase-3caspase-9cell typedrug discoveryembryonic stem cellgenetic regulatory proteininsightloss of functionmutantpluripotencyregenerative therapyresearch studyself-renewalsmall hairpin RNAstem cell differentiationstem cell divisionstem cell fatetooltranscription factortransplantation medicine
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Embryonic stem (ES) cells are pluripotent and can expand in vitro without any apparent limits, while retaining
their ability to become any type of cell in the body. The long-term goal of this proposal is to link the molecular
mechanisms of programmed cell death to those underlying ES cell renewal and differentiation, with a view
toward accelerating the clinical introduction of ES cell regenerative medicine. In my preliminary studies, I
found that caspase-3, an important mediator of programmed cell death, has an unexpected role in controlling
ES cell fate. I demonstrate an increase of caspase-3 activity upon induction of differentiation and show that
caspase-3 can directly cleave the Nanog transcription factor, leading to rapid loss of this core pluripotency-
related protein and subsequent ES cell differentiation it typically mediates. These results suggest that caspase-
3 and perhaps other key components of the programmed cell death pathway may have an integral role in the
regulation of ES cell renewal/differentiation.
The central hypothesis of this proposed work is that classical mediators of programmed cell death, especially
caspase-3, also mediate the fate decisions affecting pluripotent stem cells. In Aim 1 I will dissect the functional
roles of caspase-3 and its activating caspase in the fate of ES cells. In Aim 2 I will modulate caspase activity
in ES cells and assess the effects on self-renewal, differentiation and programmed cell death. I will also
address the question of whether the differentiation-promoting activity of caspase-3 in ES cells is due to an
instructive or selective signaling and elucidate if caspase activity provides a specific signal to differentiate or
simply promotes differentiation in general. In Aim 3 I will assess the importance of caspase-3-mediated
cleavage of Nanog in ES cell differentiation. I consider the transcription factor Nanog to be a paradigm for
other potential caspase targets in ES cells, so that my findings for this regulatory protein could well extend to
other transcriptional pathways involved in ES cell differentiation.
Results of the experiments described in this proposal are expected to provide insight into the pleiotropic effects
of caspases in pluripotent stem cells. Thus, specific pharmacological alteration of caspases may be useful not
only for modulating apoptosis, but also for directing stem cell fate. The involvement of caspases in
nonapoptotic pathways suggests that efforts to block apoptosis via caspase inhibition could have much
broader consequences than initially thought. The ability of embryonic stem cells to remain undifferentiated in culture while retaining the ability to become
any cell within the human body make them an invaluable tool for use in transplant medicine, drug discovery,
and understanding basic developmental biology. Results of the experiments described in this proposal are
expected to provide insight into the pleiotropic effects of the cell death enzyme caspase on the differentiation
process of embryonic stem cells. Specific pharmacological alteration of caspases may be useful not only for
modulating programmed cell death, but also for directing stem cell fate.
期刊论文(7)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
10.1371/journal.pbio.1001268
发表时间:
2012
期刊:
PLoS biology
影响因子:
9.8
作者:
[Jain AK, Allton K, Iacovino M, Mahen E, Milczarek RJ, Zwaka TP, Kyba M, Barton MC]
通讯作者:
Barton MC
Generation of hiPSTZ16 (ISMMSi003-A) cell line from normal human foreskin fibroblasts.
从正常人包皮成纤维细胞生成 hiPSTZ16 (ISMMSi003-A) 细胞系。
DOI:
10.1016/j.scr.2017.11.019
发表时间:
2018
期刊:
Stem cell research
影响因子:
1.2
作者:
[Dejosez,Marion, Zwaka,ThomasP]
通讯作者:
Zwaka,ThomasP
DOI:
10.1016/j.scr.2017.06.014
发表时间:
2017-08
期刊:
Stem cell research
影响因子:
1.2
作者:
[Seifert BA, Dejosez M, Zwaka TP]
通讯作者:
Zwaka TP
DOI:
10.7554/elife.12175
发表时间:
2016-01-29
期刊:
eLife
影响因子:
7.7
作者:
[Skinner SO, Xu H, Nagarkar-Jaiswal S, Freire PR, Zwaka TP, Golding I]
通讯作者:
Golding I
Bat pluripotent stem cells as a novel experimental system
-
批准号:10592777
-
项目类别:
-
资助金额:$25.35万
-
财政年份:2023
-
负责人:Thomas P. Zwaka
-
依托单位:
Protection of early embryogenesis and pluripotent stem cells against genetic parasites through a primitive immune system
-
批准号:10356153
-
项目类别:
-
资助金额:$34.47万
-
财政年份:2020
-
负责人:Thomas P. Zwaka
-
依托单位:
Protection of early embryogenesis and pluripotent stem cells against genetic parasites through a primitive immune system
-
批准号:10570214
-
项目类别:
-
资助金额:$34.47万
-
财政年份:2020
-
负责人:Thomas P. Zwaka
-
依托单位:
An inquiry into the function of Ronin in embryogenesis and pluripotent stem cells
-
批准号:9897561
-
项目类别:
-
资助金额:$46.61万
-
财政年份:2018
-
负责人:Thomas P. Zwaka
-
依托单位:
NON-APOPTOTIC ACTION OF CASPASES IN PLURIPOTENT EMBRYONIC STEM CELLS
-
批准号:7826576
-
项目类别:
-
资助金额:$30.39万
-
财政年份:2008
-
负责人:Thomas P. Zwaka
-
依托单位:
NON-APOPTOTIC ACTION OF CASPASES IN PLURIPOTENT EMBRYONIC STEM CELLS
-
批准号:7655456
-
项目类别:
-
资助金额:$30.7万
-
财政年份:2008
-
负责人:Thomas P. Zwaka
-
依托单位:
NON-APOPTOTIC ACTION OF CASPASES IN PLURIPOTENT EMBRYONIC STEM CELLS
-
批准号:8073463
-
项目类别:
-
资助金额:$30.09万
-
财政年份:2008
-
负责人:Thomas P. Zwaka
-
依托单位:
NON-APOPTOTIC ACTION OF CASPASES IN PLURIPOTENT EMBRYONIC STEM CELLS
-
批准号:7522733
-
项目类别:
-
资助金额:$30.7万
-
财政年份:2008
-
负责人:Thomas P. Zwaka
-
依托单位:
Thanatos-Associated Protein 11 (Thap11) in Human Embryonic Stem Cells
-
批准号:7356524
-
项目类别:
-
资助金额:$22.75万
-
财政年份:--
-
负责人:Thomas P. Zwaka
-
依托单位:
Thanatos-Associated Protein 11 (Thap11) in Human Embryonic Stem Cells
-
批准号:7678452
-
项目类别:
-
资助金额:$22.67万
-
财政年份:--
-
负责人:Thomas P. Zwaka
-
依托单位:
Thanatos-Associated Protein 11 (Thap11) in Human Embryonic Stem Cells
-
批准号:7915185
-
项目类别:
-
资助金额:$23.23万
-
财政年份:--
-
负责人:Thomas P. Zwaka
-
依托单位:
海外基金